NCT05263024Not yet recruiting
Study on the Significance of Auricular Clip in Prevention and Treatment of Valvular Heart Disease Atrial Thrombosis
Study on the Significance of Auricular Clip in Prevention and Treatment of Valvular Heart Disease Atrial Thrombosis and the Related Precision Treatment Technique
Source: ClinicalTrials.gov · Last updated 2 Mar 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To evaluate the safety and clinical efficacy of left atrial appendage in the prevention of thrombus in patients with valvular heart disease, to improve the product according to clinical conditions, to achieve clinically accurate treatment, and to establish the heart valve, the usefulness and universality of Warfarin's anticoagulant model were verified by the specimen library
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 118 (estimated)
- First submitted
- 20 Feb 2022
- Start date
- 21 Feb 2022
- Primary completion date
- 22 Mar 2025
- Lead sponsor
- Second Affiliated Hospital of Nanchang University
- Diseases
- Atrial fibrillation
- NCT number
- NCT05263024
What you commit to
- Study type: Observational
- Planned participants: 118
- From 21 Feb 2022 to the primary completion date, 22 Mar 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Failed to reach the end point in clinical trials of other drugs or devices
Other illness
- She had a history of open heart surgery with extensive adhesion of the pericardium
Other
- Patients whose left atrial appendage has been resected or occluded
- Patients cannot be returned due to other reasons
- X-ray is contraindicated or not suitable for TEE examination
- Those who are considered unsuitable for the clinical trial by the investigator
Who the study is looking for
- Patients with valvular heart disease aged between 18 and 75
- Valvular heart disease \[Cardiovascular Surgery Volume, Clinical Diagnosis and Treatment Guidelines, Chinese Medical Association (2011 edition)\]
- Preoperative cardiac function grade II-III (NYHA), no operation-related contraindications
- Understand the nature of this study, agree to participate in all terms of this study, sign informed consent, agree to accept postoperative treatment plan and follow-up requirements, and cooperate to complete follow-up
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.